© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 8, 632-633,
April 17, 2002
© 2002 Oxford University Press
CORRESPONDENCE |
Re: Helicobacter pylori Seropositivity as a Risk Factor for Pancreatic Cancer
Affiliations of authors: H.-O. Nilsson, T. Wadström (Department of Medical Microbiology, Dermatology and Infection), U. Stenram, (Department of Pathology), I. Ihse (Department of Surgery), Lund University, Lund, Sweden.
Correspondence to: Torkel Wadström, M.D., Ph.D., Dept. of Medical Microbiology, Dermatology and Infection, Lund University, Sölvegatan 23, SE-223 62 LUND, Sweden (e-mail: Torkel.Wadstrom@mmb.lu.se).
In the study of Helicobacter pylori seropositivity as a risk factor for pancreatic cancer, Stolzenberg-Solomon et al. (1) concluded that their findings support a possible role for the presence of H. pylori in the development of pancreatic cancer. We recently reported the identification of Helicobacter species in the livers of patients with hepatocellular carcinoma and cholangiocarcinoma (2) and in
NOTES
REFERENCES
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. de Martel, A. E. Llosa, G. D. Friedmana, J. H. Vogelman, N. Orentreich, R. Z. Stolzenberg-Solomon, and J. Parsonnet Helicobacter pylori Infection and Development of Pancreatic Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1188 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nilsson, I. Kornilovs'ka, S. Lindgren, A. Ljungh, and T. Wadstrom Increased prevalence of seropositivity for non-gastric Helicobacter species in patients with autoimmune liver disease J. Med. Microbiol., November 1, 2003; 52(11): 949 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Risch Etiology of Pancreatic Cancer, With a Hypothesis Concerning the Role of N-Nitroso Compounds and Excess Gastric Acidity J Natl Cancer Inst, July 2, 2003; 95(13): 948 - 960. [Abstract] [Full Text] [PDF] |
||||


